Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Samaraenergo reported for 6 months of 2024 by RAS

7/29/24 SAGO

TNS Energo Voronezh reported for 6 months of 2024 by RAS

7/29/24 VRSB

TNS Energo Rostov-on-Don reported for 6 months of 2024 by RAS

7/29/24 RTSB

UWC reported for 6 months of 2024 by RAS

7/29/24 UWGN

APRI IPO went over the top

7/29/24 APRI

Zvezda reported for 6 months of 2024 by RAS

7/29/24 ZVEZ

Nornickel reports for 6 months of 2024 by RAS

7/29/24 GMKN

TGC-2 reported for 6 months of 2024 by RAS

7/29/24 TGKB

Ryazanenergosbyt reported for 6 months of 2024 by RAS

7/29/24 RZSB

INARCTICA reported for 6 months of 2024 by RAS

7/29/24 AQUA